-
Cellares Expands Global Smart Factory Network With European Headquarters in the Netherlands
12 Jan 2026 18:32 GMT
… capacity a practical requirement for European programs,” said Fabian Gerlinghaus, …
pr@cellares.com
KEYWORD: EUROPE UNITED STATES NETHERLANDS NORTH AMERICA … MANUFACTURING HEALTH TECHNOLOGY MANUFACTURING BIOTECHNOLOGY OTHER HEALTH HEALTH PHARMACEUTICAL OTHER …
-
n-Lorem and EspeRare announce European collaboration to expand access to individualized ASO Therapies for Rare Genetic Diseases
12 Jan 2026 19:04 GMT
… . EspeRare's experience navigating European regulatory systems and enabling access … shared commitment to building durable, Europe-focused pathways for individualized genetic … therapies for rare diseases. Combining biotech agility with a mission-driven …
-
Biogen Receives European Commission Approval for High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
12 Jan 2026 16:05 GMT
… Nasdaq: BIIB) today announced the European Commission (EC) has granted … at www.ema.europa.eu. The high dose regimen … Biogen is a leading biotechnology company that pioneers innovative science … 2015; 12:290–302.
European Medicines Agency. SPINRAZA Summary of …
-
One in three Imec researchers comes from outside the EU
12 Jan 2026 14:02 GMT
… of researchers from outside the European Union is rising in Flemish … . Most are from outside the EU. Over the past five years … , the share of non-EU researchers has risen from 25 … . At the Flemish Institute for Biotechnology (VIB) it went up slightly …
-
Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference
12 Jan 2026 13:00 GMT
… NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader … Executive Officer of Legend Biotech. “Legend Biotech is poised for transformative growth … and Drug Administration (FDA) and European Commission (EC) approval to include …
-
Female-led Swiss BioTech FluoSphera secures €1.23 million to advance animal-free, human-relevant drug discovery
12 Jan 2026 09:46 GMT
Geneva-based BioTech startup FluoSphera today announced that … scaling in the US and EU, as it takes initial steps …
-
European shares slip as banks slide on Trump’s credit card fee cap plan
12 Jan 2026 08:47 GMT
Jan 12 (Reuters) – European shares dipped on Monday as … weighed on banks.
The pan-European STOXX 600 slipped 0.2% … the Nasdaq-100 index.
French biotech Abivax surged 22.8%. In …
-
Krystal Biotech Reports ~$389M 2025 VYJUVEK Revenue, $955M Cash Reserves
12 Jan 2026 05:26 GMT
(RTTNews) - Krystal Biotech Inc. (KRYS) announced preliminary unaudited … VYJUVEK in an additional major European market, expanding its specialty distributor … -based compensation.
Shares of Krystal Biotech closed at $261.41 on …
-
Celltrion clears patent hurdles to launch Eylea biosimilar in US, Europe
12 Jan 2026 04:54 GMT
… the original pharmaceutical company.
In Europe, Celltrion received approval from the … unfavorable precedents set by other biotech companies that lost similar lawsuits … injunctions banning sales across multiple European countries, the Munich court limited …
-
Which biotech company's shares have rocketed to a new high on good news?
12 Jan 2026 03:53 GMT
… at $1.84. The biotechnology company said in its statement … in the US. ASX biotech medical innovation The catheter, … noted and remembered. ASX biotech product suite growing The company … launched NorthStar comedically in Europe. In Europe we are already seeing …